Pharma labeling is a critical but complex process where even small oversights can have major regulatory and financial ...

The issuer is solely responsible for the content of this announcement. Correction to the publication dated 02.09.2025, 10:30 a.m. (CEST) – The Platform Group Targets EUR 1 Billion in Revenue for 2026, ...

Corbus Pharmaceuticals (CRBP) announced data from its Phase 1/2 clinical study of CRB-701 will be presented as a poster at the 2025 European ...

Subscription and guarantee commitments totaling €5.9 million, representing 75.5% of the envisaged capital increase Subscription price: €1.80 per share, representing a 29.4% discount to the closing ...